Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             85 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A cardinal sin when researching neuropsin/KLK8: Thou shalt validate antibodies Lahiri, Debomoy K.
2017
9 p. 1068-1069
artikel
2 Alzheimer's Association Update 2015
9 p. 1127-1129
3 p.
artikel
3 Amyloid-beta oligomerization is associated with the generation of a typical peptide fragment fingerprint Rudinskiy, Nikita
2016
9 p. 996-1013
18 p.
artikel
4 Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort Tosun, Duygu
2016
9 p. 977-986
10 p.
artikel
5 APOE-ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies Saeed, Usman
2018
9 p. 1137-1147
artikel
6 Big data to smart data in Alzheimer's disease: Real-world examples of advanced modeling and simulation Haas, Magali
2016
9 p. 1022-1030
9 p.
artikel
7 Big data to smart data in Alzheimer's disease: The brain health modeling initiative to foster actionable knowledge Geerts, Hugo
2016
9 p. 1014-1021
8 p.
artikel
8 Boosting translational research on Alzheimer's disease in Europe: The Innovative Medicine Initiative AD research platform Vaudano, Elisabetta
2015
9 p. 1121-1122
2 p.
artikel
9 Brain rhythm attractor breakdown in Alzheimer's disease: Functional and pathologic implications Karageorgiou, Elissaios
2017
9 p. 1054-1067
artikel
10 Can we rely only on ratios of cerebrospinal fluid biomarkers for AD biological diagnosis? Lehmann, Sylvain
2015
9 p. 1125-1126
2 p.
artikel
11 Cerebrospinal fluid tau, Aβ, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration Alosco, Michael L.
2018
9 p. 1159-1170
artikel
12 Clinicopathologic subtype of Alzheimer's disease presenting as corticobasal syndrome Sakae, Nobutaka

9 p. 1218-1228
artikel
13 Cognitive decline associated with pathological burden in primary age-related tauopathy Jefferson-George, Kyra S.
2017
9 p. 1048-1053
artikel
14 Combination therapy for Alzheimer's disease: Are we ready? Salloway, Stephen
2018
9 p. 1232-1233
artikel
15 Considering new treatment paradigms for neuropsychiatric symptoms of Alzheimer’s disease Lanctôt, Krista L.
2016
9 p. 1031-1032
2 p.
artikel
16 Contents 2017
9 p. A1-A2
artikel
17 Contents 2018
9 p. A1-A2
artikel
18 Contents 2016
9 p. A1-A2
nvt p.
artikel
19 Contents 2015
9 p. A1-A2
nvt p.
artikel
20 Contents
9 p. A1-A2
artikel
21 Dementia registries around the globe and their applications: A systematic review Krysinska, Karolina
2017
9 p. 1031-1047
artikel
22 Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease Dubois, Bruno
2015
9 p. 1041-1049
9 p.
artikel
23 Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β Mormino, Elizabeth C.
2017
9 p. 1004-1012
artikel
24 Early pathologic amyloid induces hypersynchrony of BOLD resting-state networks in transgenic mice and provides an early therapeutic window before amyloid plaque deposition Shah, Disha
2016
9 p. 964-976
13 p.
artikel
25 Editorial Board 2016
9 p. A3-
1 p.
artikel
26 Editorial Board 2017
9 p. A3
artikel
27 Editorial Board 2018
9 p. A3-A4
artikel
28 Editorial Board 2015
9 p. A3-
1 p.
artikel
29 Editorial Board
9 p. A3-A4
artikel
30 Effect of Alzheimer's disease risk and protective factors on cognitive trajectories in subjective memory complainers: An INSIGHT-preAD study Teipel, Stefan J.
2018
9 p. 1126-1136
artikel
31 Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies–like model Mandler, Markus

9 p. 1133-1148
artikel
32 Epilepsy and Alzheimer's disease: Overlapping mechanisms and therapeutic opportunities Alzheimer's,

9 p. 1240-1241
artikel
33 Ethical adoption: A new imperative in the development of technology for dementia Robillard, Julie M.
2018
9 p. 1104-1113
artikel
34 18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET Ottoy, Julie

9 p. 1172-1182
artikel
35 Fractal regulation and incident Alzheimer's disease in elderly individuals Li, Peng
2018
9 p. 1114-1125
artikel
36 Frequency and longitudinal clinical outcomes of Alzheimer's AT(N) biomarker profiles: A longitudinal study Yu, Jin-Tai

9 p. 1208-1217
artikel
37 Gamma glutamyltransferase and risk of future dementia in middle-aged to older Finnish men: A new prospective cohort study Kunutsor, Setor K.
2016
9 p. 931-941
11 p.
artikel
38 Guidelines for reporting methodological challenges and evaluating potential bias in dementia research Weuve, Jennifer
2015
9 p. 1098-1109
12 p.
artikel
39 Helicobacter pylori seropositivity and its association with incident all-cause and Alzheimer's disease dementia in large national surveys Beydoun, May A.
2018
9 p. 1148-1158
artikel
40 Hemodynamic changes in Alzheimer's disease: A leading role behind the courtain? Commentary on “CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease” by Lista et al. Diomedi, Marina
2015
9 p. 1123-1124
2 p.
artikel
41 Hypothesis: cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathology Meyer, Pierre-François

9 p. 1160-1171
artikel
42 Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions Varley, James
2015
9 p. 1110-1120
11 p.
artikel
43 Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials Donohue, Michael C.
2015
9 p. 1069-1079
11 p.
artikel
44 Medical and Scientific Advisory Council 2017
9 p. A4
artikel
45 Medical and Scientific Advisory Council 2018
9 p. A5
artikel
46 Medical and Scientific Advisory Council 2016
9 p. A4-
1 p.
artikel
47 Medical and Scientific Advisory Council 2015
9 p. A4-
1 p.
artikel
48 Medical and Scientific Advisory Council
9 p. A5
artikel
49 Mediterranean diet and preserved brain structural connectivity in older subjects Pelletier, Amandine
2015
9 p. 1023-1031
9 p.
artikel
50 Metabolic network failures in Alzheimer's disease: A biochemical road map Toledo, Jon B.
2017
9 p. 965-984
artikel
51 Methylation profiles in peripheral blood CD4+ lymphocytes versus brain: The relation to Alzheimer's disease pathology Yu, Lei
2016
9 p. 942-951
10 p.
artikel
52 MIND diet associated with reduced incidence of Alzheimer's disease Morris, Martha Clare
2015
9 p. 1007-1014
8 p.
artikel
53 MIND diet slows cognitive decline with aging Morris, Martha Clare
2015
9 p. 1015-1022
8 p.
artikel
54 Multiple BACE1 inhibitors abnormally increase the BACE1 protein level in neurons by prolonging its half-life Liu, Lei

9 p. 1183-1194
artikel
55 Neuropsychological latent classes at enrollment and postmortem neuropathology Zammit, Andrea R.

9 p. 1195-1207
artikel
56 Paul Greengard, Ph.D. (1925-2019) Gandy, Sam

9 p. 1229-1235
artikel
57 Potential roles of digital technologies in clinical trials Czaja, Sara
2017
9 p. 1075-1076
artikel
58 Reply to “Down Syndrome Cognitive Marker's Significance in Alzheimer's Disease and Dementia Management” Startin, Carla M.

9 p. 1238-1239
artikel
59 Response letter Keyvani, Kathy
2017
9 p. 1070-1071
artikel
60 Safety of disclosing amyloid status in cognitively normal older adults Burns, Jeffrey M.
2017
9 p. 1024-1030
artikel
61 Self-rated and informant-rated everyday function in comparison to objective markers of Alzheimer's disease Rueda, Alicia D.
2015
9 p. 1080-1089
10 p.
artikel
62 Self-reported sleep disturbance is associated with Alzheimer's disease risk in men Benedict, Christian
2015
9 p. 1090-1097
8 p.
artikel
63 Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts Buckley, Rachel F.
2018
9 p. 1193-1203
artikel
64 Sex and gender in Alzheimer's disease – Does it matter? Mielke, Michelle M.
2018
9 p. 1101-1103
artikel
65 Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints Cavedo, Enrica
2018
9 p. 1204-1215
artikel
66 Sex-related differences in the prevalence of cognitive impairment among overweight and obese adults with type 2 diabetes Espeland, Mark A.
2018
9 p. 1184-1192
artikel
67 SORLA regulates calpain-dependent degradation of synapsin Hartl, Daniela
2016
9 p. 952-963
12 p.
artikel
68 Spatial navigation and risk of cognitive impairment: A prospective cohort study Verghese, Joe
2017
9 p. 985-992
artikel
69 Subscriber Information 2017
9 p. A5
artikel
70 Subscriber Information 2018
9 p. A6
artikel
71 Subscriber Information 2016
9 p. A5-
1 p.
artikel
72 Subscriber Information 2015
9 p. A5-
1 p.
artikel
73 Subscriber Information
9 p. A6
artikel
74 Sugary beverage intake and preclinical Alzheimer's disease in the community Pase, Matthew P.
2017
9 p. 955-964
artikel
75 The Alzheimer's Disease Exposome Finch, Caleb E.

9 p. 1123-1132
artikel
76 The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study Bosco, Paolo
2017
9 p. 1013-1023
artikel
77 The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data Schmidt, Mark E.
2015
9 p. 1050-1068
19 p.
artikel
78 The pitfalls of biomarker-based classification schemes Illán-Gala, Ignacio
2017
9 p. 1072-1074
artikel
79 The validity of the Memory Alteration Test and the Test Your Memory test for community-based identification of amnestic mild cognitive impairment Ozer, Seline
2016
9 p. 987-995
9 p.
artikel
80 Transcranial direct current stimulation in mild cognitive impairment: Behavioral effects and neural mechanisms Meinzer, Marcus
2015
9 p. 1032-1040
9 p.
artikel
81 Traumatic brain injury and Alzheimer's disease neuropathology Jellinger, Kurt A.

9 p. 1236-1237
artikel
82 Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease Baldacci, Filippo
2017
9 p. 993-1003
artikel
83 Understanding the impact of sex and gender in Alzheimer's disease: A call to action Nebel, Rebecca A.
2018
9 p. 1171-1183
artikel
84 Use of nonintrusive sensor-based information and communication technology for real-world evidence for clinical trials in dementia Teipel, Stefan
2018
9 p. 1216-1231
artikel
85 Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease Bos, Isabelle

9 p. 1149-1159
artikel
                             85 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland